Company News Archive Ebitda Increased To Nok 302 Million In Q1
EBITDA increased to NOK 302 million in Q1

EBITDA increased to NOK 302 million in Q1

All business areas improved their results compared with the corresponding quarter in 2020. The net currency impact on EBITDA 1 was negative compared with the 1 st quarter of 2020.

EBITDA 1 in BioSolutions improved as a result of price increases for certain biopolymer applications and reduced costs. The BioMaterials result improved due to high deliveries of speciality cellulose and a favourable product mix which more than compensated for lower sales prices. In Fine Chemicals, the effect of low deliveries was more than offset by a favourable product mix for fine chemical intermediates and a high production volume of bioethanol.

Profit before tax was NOK 176 million (NOK 111 million). Earnings per share was NOK 1.47 (NOK 1.02).

- We are pleased to deliver a strong result with improvement in all business areas, says President and CEO Per A. Sørlie.

 

Contacts :
Director Investor Relations, Jørn Syvertsen, +47 958 36 335
Director Communication, Tone Horvei Bredal, +47 924 67 711

 

  1. Operating profit before depreciation, amortisation and other income and expenses
  2. Figures in parentheses are for the corresponding period in the preceding year

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.